Skip to main content
logo
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
25.22
+0.07 (0.28%)
At close: Aug 27, 2026

SHE:300937 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
4,4774,4544,3954,4303,9693,401
Revenue Growth
3.49%1.35%-0.81%11.62%16.72%21.88%
Gross Profit
427.45459.48382.22357.85306.05181.48
Operating Income
24.1927.9425.4173.9758.190.04
Net Income
-14.76-12.8513.259.5342.026.4
Earnings Per Share
-0.15-0.130.170.620.440.07
EPS Growth
---72.58%40.91%528.57%-90.67%

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Wholesale - Terminal Pure Sales
2,4242,2642,3632,3722,111
Pharmaceutical Wholesale - Commercial Distribution
1,5111,7521,9741,5421,246
Pharmaceutical Industry
367.53232.3239.3312.6812.55
Pharmaceutical Retail
117.88112.2130.3119.5914.38
health products, technologies and services
33.0634.6823.5423.6516.23
Total
4,4544,3954,4303,9693,401

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
515.89418.64392.5379.69464.82153.78
Total Debt
299.79334.74388.85329.63243.62129.8
Net Cash (Debt)
216.183.893.6550.06221.2123.98
Net Cash Growth
1068.09%2200.11%-92.72%-77.37%822.60%-67.68%
Net Cash Per Share
2.250.880.050.522.320.26

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
1.2-13.23124.43-115.47152.67-154.38
Capital Expenditures
-8.93-7.57-32.41-35.33-18.32-31.43
Free Cash Flow
-7.73-20.892.02-150.8134.35-185.81
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
9.55%10.32%8.70%8.08%7.71%5.34%
Operating Margin
0.54%0.63%0.58%1.67%1.47%0.00%
Pretax Margin
-0.18%0.16%0.27%1.58%1.13%0.24%
Profit Margin
-0.33%-0.29%0.30%1.34%1.06%0.19%
FCF Margin
-0.17%-0.47%2.09%-3.40%3.38%-5.46%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23
Dividend Per Share
0.100-0.1000.2200.200
Dividend Per Share Growth
-54.55%--54.55%10.00%-
Dividend Yield
0.40%-0.40%0.71%0.71%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
--181.3350.5465.71680.87
P/FCF Ratio
--26.01-20.55-
PS Ratio
0.540.730.550.680.701.28